Vaccines

As a national health emergency, more preventative measures are in place to contain this crisis, while also providing more funds towards developing and evaluating vaccines and drugs. With increasing pressure, the Biden administration had been criticized for moving too slowly with the distribution of…

The European Medicines Agency is recommending that the Novavax COVID-19 has a warning of 2 possible heart inflammations. On Wednesday the EMA made this statement due to a few cases of myocarditis and pericarditis after taking the shot. Novavax claims that there were no issues with heart…

The White House has decided to offer new COVID-19 booster vaccines by September. The new shots will be geared toward fighting the new extremely contagious omicron subvariants BA.5 and BA.4. The Biden administration has purchased millions of the retooled booster vaccines from pharmaceutical…

  The Centers for Disease Control and Prevention on Tuesday signed off on Novavax's two-dose Covid-19 vaccine. Dr. Rochelle Walensky, director of the CDC, along with the rest of the CDC committee voted to unanimously recommend the use of the new vaccine as a two-dose primary series in adults. The…

Pfizer announced on Monday that their long-awaited vaccine for young children was found to elicit a strong immune response with no significant adverse effects. The dose given to the children was one-tenth the dose given to adults which were found to be well tolerated by their immune systems.…

As the US nears 1 million deaths due to COVID-19 infection, Americans 65 and older continue to account for about 75% of all US covid deaths. Despite this, 1 in 3 people 65 and older who have already received their initial round of vaccinations still have not received a first booster shot though the…

Moderna has announced the development of a new version of their COVID-19 vaccine. A study has shown the vaccine to be stronger, longer-lasting, and more effective against variants than the original vaccine. The vaccine is intended to target the original strain of COVID-19 and the beta variant,…

The FDA has approved a second booster COVID-19 vaccine dose for people 50 and older and some people with underlying conditions. This decision comes as a result of months of scientific debate on the necessity and efficacy of a 4th booster shot. Evidence suggests that the third booster surge saved…

Researchers from the New York State Department of Health have found the low-dose version of the Pfizer-BioNTech COVID-19 vaccine given to children ages 5-11 to be less likely to prevent infection compared to the high-dose version given to people past the age of 12. Although all doses were shown to…

New research has suggested that a fourth COVID-19 vaccine dose may not be needed for most people. John Wherry, director of the Institute for immunology at the University of Pennsylvania has said the elderly or people at high risk of infection could benefit from a fourth vaccination but for others,…

The Omicron variant of the COVID-19 virus is likely the fastest-spreading virus in human history. Omicron is so contagious that one infection can create six new cases after just four days, and more than 200 cases after 12 days. As a comparison, the measles virus might infect only 15 other people in…

After leading much of the developed world in first and second vaccination rates, the United States is now falling behind other Western countries in booster rates. According to Our World in data 28% of Americans have received a booster compared to 55% of the United Kingdom, 51% of France, and 44% of…

Sweden has joined a small list of nations to recommend a fourth COVID-19 vaccination. On Monday Sweden’s public health agency recommended that people 80 years and older take a second booster shot. Research done by the U.S. Centers for Disease Control and Prevention has shown booster shot efficacy…

Experts in India have begun research on a COVID-19 vaccine that would be applied nasally rather than injected into the bloodstream. With the rise of variants such as Omicron, current COVID-19 vaccines have seen a decrease in long-term protection against the coronavirus. Nasal vaccines could be a…